Murine leukemia virus Gag localizes to the uropod of migrating primary lymphocytes

Journal of Virology

Volumn 88, Issue 18, 2014, Pages 10541-10555

  Li, Fei ^a   Sewald, Xaver ^a   Jin, Jing ^a   Sherer, Nathan M ^a,b   Mothes, Walther ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL MEMBRANE; CELL SURFACE; CONTROLLED STUDY; LYMPHOCYTE MIGRATION; MOUSE; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN MULTIMERIZATION; VIRION; VIRUS INFECTION; VIRUS PARTICLE; VIRUS RELEASE; WILD TYPE; ANIMAL; CELL CULTURE; CELL MOTION; CELL POLARITY; CYTOLOGY; FRIEND LEUKEMIA VIRUS; GENETICS; METABOLISM; PATHOPHYSIOLOGY; PROTEIN TRANSPORT; RETROVIRUS INFECTION; RODENT DISEASE; T LYMPHOCYTE; VETERINARY; VIROLOGY;

ANIMALS; B-LYMPHOCYTES; CELL MEMBRANE; CELL MOVEMENT; CELL POLARITY; CELLS, CULTURED; FRIEND MURINE LEUKEMIA VIRUS; GENE PRODUCTS, GAG; MICE; PROTEIN TRANSPORT; RETROVIRIDAE INFECTIONS; RODENT DISEASES; T-LYMPHOCYTES;

EID: 84906349765     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01104-14     Document Type: Article

References (78)

1. Morita E, Sundquist WI. 2004. Retrovirus budding. Annu. Rev. Cell Dev. Biol. 20:395-425. http://dx.doi.org/10.1146/annurev.cellbio.20.010403.102350.
2. Balasubramaniam M, Freed EO. 2011. New insights into HIV assembly and trafficking. Physiology (Bethesda) 26:236-251. http://dx.doi.org/10.1152/physiol.00051.2010.
3. Gottlinger HG. 2001. The HIV-1 assembly machine. AIDS 15:S13-S20. http://dx.doi.org/10.1097/00002030-200100005-00003.
4. Briggs JAG, Krausslich HG. 2011. The molecular architecture of HIV. J. Mol. Biol. 410:491-500. http://dx.doi.org/10.1016/j.jmb.2011.04.021.
5. Ehrlich LS, Agresta BE, Carter CA. 1992. Assembly of recombinant human immunodeficiency virus type 1 capsid protein in vitro. J. Virol. 66:4874-4883.
6. Gamble TR, Yoo S, Vajdos FF, von Schwedler UK, Worthylake DK, Wang H, McCutcheon JP, Sundquist WI, Hill CP. 1997. Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein. Science 278:849-853. http://dx.doi.org/10.1126/science.278.5339.849.
7. Coffin JM, Hughes SH, Varmus H. 1997. Retroviruses. Cold Spring Harbor Laboratory Press, Plainview, NY.
8. Mortuza GB, Haire LF, Stevens A, Smerdon SJ, Stoye JP, Taylor IA. 2004. High-resolution structure of a retroviral capsid hexameric amino-terminal domain. Nature 431:481-485. http://dx.doi.org/10.1038/nature02915.
9. Martin-Serrano J, Eastman SW, Chung W, Bieniasz PD. 2005. HECT ubiquitin ligases link viral and cellular PPXY motifs to the vacuolar protein-sorting pathway. J. Cell Biol. 168:89-101.
10. Martin-Serrano J, Zang T, Bieniasz PD. 2001. HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress. Nat. Med. 7:1313-1319. http://dx.doi.org/10.1038/nm1201-1313.
11. Göttlinger HG, Dorfman T, Sodroski JG, Haseltine WA. 1991. Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. Proc. Natl. Acad. Sci. U. S. A. 88:3195-3199. http://dx.doi.org/10.1073/pnas.88.8.3195.
12. Martin-Serrano J, Zang T, Bieniasz PD. 2003. Role of ESCRT-I in retroviral budding. J. Virol. 77:4794-4804. http://dx.doi.org/10.1128/JVI.77.8.4794-4804.2003.
13. Martin-Serrano J, Neil SJD. 2011. Host factors involved in retroviral budding and release. Nat. Rev. Microbiol. 9:519-531. http://dx.doi.org/10.1038/nrmicro2596.
14. Ono A. 2009. HIV-1 assembly at the plasma membrane: Gag trafficking and localization. Future Virol. 4:241-257. http://dx.doi.org/10.2217/fvl.09.4.
15. Jouvenet N, Neil SJ, Bess C, Johnson MC, Virgen CA, Simon SM, Bieniasz PD. 2006. Plasma membrane is the site of productive HIV-1 particle assembly. PLoS Biol. 4:e435. http://dx.doi.org/10.1371/journal.pbio.0040435.
16. Finzi A, Orthwein A, Mercier J, Cohen EA. 2007. Productive human immunodeficiency virus type 1 assembly takes place at the plasma membrane. J. Virol. 81:7476-7490. http://dx.doi.org/10.1128/JVI.00308-07.
17. Rudner L, Nydegger S, Coren LV, Nagashima K, Thali M, Ott DE. 2005. Dynamic fluorescent imaging of human immunodeficiency virus type 1 gag in live cells by biarsenical labeling. J. Virol. 79:4055-4065. http://dx.doi.org/10.1128/JVI.79.7.4055-4065.2005.
18. Welsch S, Keppler OT, Habermann A, Allespach I, Krijnse-Locker J, Krausslich HG. 2007. HIV-1 buds predominantly at the plasma membrane of primary human macrophages. PLoS Pathog. 3(3):e36. http://dx.doi.org/10.1371/journal.ppat.0030036.
19. Deneka M, Pelchen-Matthews A, Byland R, Ruiz-Mateos E, Marsh M. 2007. In macrophages, HIV-1 assembles into an intracellular plasma membrane domain containing the tetraspanins CD81, CD9, and CD53. J. Cell Biol. 177:329-341. http://dx.doi.org/10.1083/jcb.200609050.
20. Suomalainen M, Hultenby K, Garoff H. 1996. Targeting of Moloney murine leukemia virus gag precursor to the site of virus budding. J. Cell Biol. 135:1841-1852. http://dx.doi.org/10.1083/jcb.135.6.1841.
21. Sherer NM, Lehmann MJ, Jimenez-Soto LF, Ingmundson A, Horner SM, Cicchetti G, Allen PG, Pypaert M, Cunningham JM, Mothes W. 2003. Visualization of retroviral replication in living cells reveals budding into multivesicular bodies. Traffic 4:785-801. http://dx.doi.org/10.1034/j.1600-0854.2003.00135.x.
22. Grigorov B, Arcanger F, Roingeard P, Darlix JL, Muriaux D. 2006. Assembly of infectious HIV-1 in human epithelial and T-lymphoblastic cell lines. J. Mol. Biol. 359:848-862. http://dx.doi.org/10.1016/j.jmb.2006.04.017.
23. Nydegger S, Foti M, Derdowski A, Spearman P, Thali M. 2003. HIV-1 egress is gated through late endosomal membranes. Traffic 4:902-910. http://dx.doi.org/10.1046/j.1600-0854.2003.00145.x.
24. Pelchen-Matthews A, Kramer B, Marsh M. 2003. Infectious HIV-1 assembles in late endosomes in primary macrophages. J. Cell Biol. 162: 443-455. http://dx.doi.org/10.1083/jcb.200304008.
25. Jolly C, Welsch S, Michor S, Sattentau QJ. 2011. The regulated secretory pathway in CD4(_) T cells contributes to human immunodeficiency virus type-1 cell-to-cell spread at the virological synapse. PLoS Pathog. 7:e1002226. http://dx.doi.org/10.1371/journal.ppat.1002226.
26. Batonick M, Favre M, Boge M, Spearman P, Honing S, Thali M. 2005. Interaction of HIV-1 Gag with the clathrin-associated adaptor AP-2. Virology 342:190-200. http://dx.doi.org/10.1016/j.virol.2005.08.001.
27. Camus G, Segura-Morales C, Molle D, Lopez-Verges S, Begon-Pescia C, Cazevieille C, Schu P, Bertrand E, Berlioz-Torrent C, Basyuk E. 2007. The clathrin adaptor complex AP-1 binds HIV-1 and MLV Gag and facilitates their budding. Mol. Biol. Cell 18:3193-3203. http://dx.doi.org/10.1091/mbc.E06-12-1147.
28. Dong XH, Li H, Derdowski A, Ding LM, Burnett A, Chen XM, Peters TR, Dermody TS, Woodruff E, Wang JJ, Spearman P. 2005. AP-3 directs the intracellular trafficking of HIV-1 Gag and plays a key role in particle assembly. Cell 120:663-674. http://dx.doi.org/10.1016/j.cell.2004.12.023.
29. Fang Y, Wu N, Gan X, Yan WH, Morrell JC, Gould SJ. 2007. Higherorder oligomerization targets plasma membrane proteins and HIV gag to exosomes. PLoS Biol. 5(6):e158. http://dx.doi.org/10.1371/journal.pbio.0050158.
30. Shen BY, Fang Y, Wu N, Gould SJ. 2011. Biogenesis of the posterior pole is mediated by the exosome/microvesicle protein-sorting pathway. J. Biol. Chem. 286:44162-44176. http://dx.doi.org/10.1074/jbc.M111.274803.
31. Zhou W, Resh MD. 1996. Differential membrane binding of the human immunodeficiency virus type 1 matrix protein. J. Virol. 70:8540-8548.
32. Murray PS, Li Z, Wang J, Tang CL, Honig B, Murray D. 2005. Retroviral matrix domains share electrostatic homology: models for membrane binding function throughout the viral life cycle. Structure 13: 1521-1531. http://dx.doi.org/10.1016/j.str.2005.07.010.
33. Spearman P, Wang JJ, Vander Heyden N, Ratner L. 1994. Identification of human immunodeficiency virus type 1 Gag protein domains essential to membrane binding and particle assembly. J. Virol. 68:3232-3242.
34. Hamard-Peron E, Muriaux D. 2011. Retroviral matrix and lipids, the intimate interaction. Retrovirology 8:15. http://dx.doi.org/10.1186/1742 -4690-8-15.
35. Ono A, Ablan SD, Lockett SJ, Nagashima K, Freed EO. 2004. Phosphatidylinositol (4,5) bisphosphate regulates HIV-1 Gag targeting to the plasma membrane. Proc. Natl. Acad. Sci. U. S. A. 101:14889-14894. http://dx.doi.org/10.1073/pnas.0405596101.
36. Hamard-Peron E, Juillard F, Saad JS, Roy C, Roingeard P, Summers MF, Darlix JL, Picart C, Muriaux D. 2010. Targeting of murine leukemia virus gag to the plasma membrane is mediated by PI(4,5)P2/PS and a polybasic region in the matrix. J. Virol. 84:503-515. http://dx.doi.org/10.1128/JVI.01134-09.
37. Saad JS, Ablan SD, Ghanam RH, Kim A, Andrews K, Nagashima K, Soheilian F, Freed EO, Summers MF. 2008. Structure of the myristylated human immunodeficiency virus type 2 matrix protein and the role of phosphatidylinositol-(4,5)-bisphosphate in membrane targeting. J. Mol. Biol. 382:434-447. http://dx.doi.org/10.1016/j.jmb.2008.07.027.
38. Saad JS, Miller J, Tai J, Kim A, Ghanam RH, Summers MF. 2006. Structural basis for targeting HIV-1 Gag proteins to the plasma membrane for virus assembly. Proc. Natl. Acad. Sci. U. S. A. 103:11364-11369. http://dx.doi.org/10.1073/pnas.0602818103.
39. Soneoka Y, Kingsman SM, Kingsman AJ. 1997. Mutagenesis analysis of the murine leukemia virus matrix protein: identification of regions important for membrane localization and intracellular transport. J. Virol. 71:5549-5559.
40. Granowitz C, Goff SP. 1994. Substitution mutations affecting a small region of the Moloney murine leukemia-virus MA gag protein block assembly and release of virion particles. Virology 205:336-344. http://dx.doi.org/10.1006/viro.1994.1650.
41. Freed EO, Orenstein JM, Bucklerwhite AJ, Martin MA. 1994. Single amino acid changes in the human-immunodeficiency virus type 1 matrix protein block virus particle production. J. Virol. 68:5311-5320.
42. Ono A, Freed EO. 2004. Cell-type-dependent targeting of human immunodeficiency virus type 1 assembly to the plasma membrane and the multivesicular body. J. Virol. 78:1552-1563. http://dx.doi.org/10.1128/JVI.78.3.1552-1563.2004.
43. Ono A, Freed EO. 1999. Binding of human immunodeficiency virus type 1 Gag to membrane: role of the matrix amino terminus. J. Virol. 73:4136- 4144.
44. Joshi A, Ablan SD, Soheilian F, Nagashima K, Freed EO. 2009. Evidence that productive human immunodeficiency virus type 1 assembly can occur in an intracellular compartment. J. Virol. 83:5375-5387. http://dx.doi.org/10.1128/JVI.00109-09.
45. Johnson DC, Huber MT. 2002. Directed egress of animal viruses promotes cell-to-cell spread. J. Virol. 76:1-8. http://dx.doi.org/10.1128/JVI.76.1.1-8.2002.
46. Hope TJ. 2007. Bridging efficient viral infection. Nat. Cell Biol. 9:243- 244. http://dx.doi.org/10.1038/ncb0307-243.
47. Sattentau Q. 2008. Avoiding the void: cell-to-cell spread of human viruses. Nat. Rev. Microbiol. 6:815-826. http://dx.doi.org/10.1038/nrmicro1972.
48. Mothes W, Sherer NM, Jin J, Zhong P. 2010. Virus cell-to-cell transmission. J. Virol. 84:8360-8368. http://dx.doi.org/10.1128/JVI.00443-10.
49. Sherer NM, Lehmann MJ, Jimenez-Soto LF, Horensavitz C, Pypaert M, Mothes W. 2007. Retroviruses can establish filopodial bridges for efficient cell-to-cell transmission. Nat. Cell Biol. 9:310-315. http://dx.doi.org/10.1038/ncb1544.
50. Sowinski S, Jolly C, Berninghausen O, Purbhoo MA, Chauveau A, Kohler K, Oddos S, Eissmann P, Brodsky FM, Hopkins C, Onfelt B, Sattentau Q, Davis DM. 2008. Membrane nanotubes physically connect T cells over long distances presenting a novel route for HIV-1 transmission. Nat. Cell Biol. 10:211-219. http://dx.doi.org/10.1038/ncb1682.
51. Jin J, Sherer NM, Heidecker G, Derse D, Mothes W. 2009. Assembly of the murine leukemia virus is directed towards sites of cell-cell contact. PLoS Biol. 7:e1000163. http://dx.doi.org/10.1371/journal.pbio.1000163.
52. Sewald X, Gonzalez DG, Haberman AM, Mothes W. 2012. In vivo imaging of virological synapses. Nat. Commun. 3:1320. http://dx.doi.org/10.1038/ncomms2338.
53. Jolly C, Kashefi K, Hollinshead M, Sattentau QJ. 2004. HIV-1 cell to cell transfer across an env-induced, actin-dependent synapse. J. Exp. Med. 199:283-293. http://dx.doi.org/10.1084/jem.20030648.
54. Chen P, Hubner W, Spinelli MA, Chen BK. 2007. Predominant mode of human immunodeficiency virus transfer between T cells is mediated by sustained Env-dependent neutralization-resistant virological synapses. J. Virol. 81:12582-12595. http://dx.doi.org/10.1128/JVI.00381-07.
55. Jin J, Li F, Mothes W. 2011. Viral determinants of polarized assembly for the murine leukemia virus. J. Virol. 85:7672-7682. http://dx.doi.org/10.1128/JVI.00409-11.
56. Li F, Jin J, Herrmann C, Mothes W. 2013. Basic residues in the matrix domain and multimerization target murine leukemia virus Gag to the virological synapse. J. Virol. 87:7113-7126. http://dx.doi.org/10.1128/JVI.03263-12.
57. Browne EP. 2011. Toll-like receptor 7 controls the anti-retroviral germinal center response. PLoS Pathog. 7:e1002293. http://dx.doi.org/10.1371/journal.ppat.1002293.
58. Fais S, Malorni W. 2003. Leukocyte uropod formation and membrane/ cytoskeleton linkage in immune interactions. J. Leukoc. Biol. 73:556-563. http://dx.doi.org/10.1189/jlb.1102568.
59. Sánchez-Madrid F, Serrador JM. 2009. Bringing up the rear: defining the roles of the uropod. Nat. Rev. Mol. Cell Biol. 10:353-359. http://dx.doi.org/10.1038/nrm2680.
60. Gómez-Moutón C, Manes S. 2007. Establishment and maintenance of cell polarity during leukocyte chemotaxis. Cell Adh. Migr. 1:69-76. http://dx.doi.org/10.4161/cam.1.2.4547.
61. Krummel MF, Macara I. 2006. Maintenance and modulation of T cell polarity. Nat. Immunol. 7:1143-1149. http://dx.doi.org/10.1038/ni1404.
62. Alonso-Lebrero JL, Serrador JM, Dominguez-Jimenez C, Barreiro O, Luque A, del Pozo MA, Snapp K, Kansas G, Schwartz-Albiez R, Furthmayr H, Lozano F, Sanchez-Madrid F. 2000. Polarization and interaction of adhesion molecules P-selectin glycoprotein ligand 1 and intercellular adhesion molecule 3 with moesin and ezrin in myeloid cells. Blood 95:2413-2419. http://bloodjournal.hematologylibrary.org/content/95/7/ 2413.long?sso-checked_1.
63. Itoh S, Susuki C, Takeshita K, Nagata K, Tsuji T. 2007. Redistribution of P-selectin glycoprotein ligand-1 (PSGL-1) in chemokine-treated neutrophils: a role of lipid microdomains. J. Leukoc. Biol. 81:1414-1421. http://dx.doi.org/10.1189/jlb.0606398.
64. Mañes S, Martinez AC. 2004. Cholesterol domains regulate the actin cytoskeleton at the leading edge of moving cells. Trends Cell Biol. 14:275- 278. http://dx.doi.org/10.1016/j.tcb.2004.04.008.
65. Gómez-Moutón C, Abad JL, Mira E, Lacalle RA, Gallardo E, Jimenez-Baranda S, Illa I, Bernad A, Manes S, Martinez-A C. 2001. Segregation of leading-edge and uropod components into specific lipid rafts during T cell polarization. Proc. Natl. Acad. Sci. U. S. A. 98:9642-9647. http://dx.doi.org/10.1073/pnas.171160298.
66. McFarland W. 1969. Microspikes on the lymphocyte uropod. Science 163:818-820. http://dx.doi.org/10.1126/science.163.3869.818.
67. Ratner S, Sherrod WS, Lichlyter D. 1997. Microtubule retraction into the uropod and its role in T cell polarization and motility. J. Immunol. 159: 1063-1067.
68. Bhalla DK, Braun J, Karnovsky MJ. 1979. Lymphocyte surface and cytoplasmic changes associated with translational motility and spontaneous capping of Ig. J. Cell Sci. 39:137-147.
69. Llewellyn GN, Hogue IB, Grover JR, Ono A. 2010. Nucleocapsid promotes localization of HIV-1 Gag to uropods that participate in virological synapses between T cells. PLoS Pathog. 6(10):e1001167. http://dx.doi.org/10.1371/journal.ppat.1001167.
70. Hatch SC, Sardo L, Chen J, Burdick R, Gorelick R, Fivash MJ, Jr, Pathak VK, Hu WS. 2013. Gag-dependent enrichment of HIV-1 RNA near the uropod membrane of polarized T cells. J. Virol. 87:11912-11915. http://dx.doi.org/10.1128/JVI.01680-13.
71. Schumacher HR, Stass SA, Creegan WJ, Weislow OS. 1979. Uropodbearing lymphocytes (hand mirror cells) in a virus-induced murine lymphoma. JNCI 63:1051-1055.
72. Llewellyn GN, Grover JR, Olety B, Ono A. 2013. HIV-1 Gag associates with specific uropod-directed microdomains in a manner dependent on its MA highly basic region. J. Virol. 87:6441-6454. http://dx.doi.org/10.1128/JVI.00040-13.
73. Czibener C, Sherer NM, Becker SM, Pypaert M, Hui EF, Chapman ER, Mothes W, Andrews NW. 2006. Ca2_ and synaptotagmin VIIdependent delivery of lysosomal membrane to nascent phagosomes. J. Cell Biol. 174:997-1007. http://dx.doi.org/10.1083/jcb.200605004.
74. Lehmann MJ, Sherer NM, Marks CB, Pypaert M, Mothes W. 2005. Actin- and myosin-driven movement of viruses along filopodia precedes their entry into cells. J. Cell Biol. 170:317-325. http://dx.doi.org/10.1083/jcb.200503059.
75. Perez-Andres M, Grosserichter-Wagener C, Teodosio C, van Dongen JJM, Orfao A, van Zelm MC. 2011. The nature of circulating CD27(+)CD43(+) Bcells. J. Exp. Med. 208:2565-2566. http://dx.doi.org/10.1084/jem.20112203.
76. Accola MA, Strack B, Gottlinger HG. 2000. Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain. J. Virol. 74:5395-5402. http://dx.doi.org/10.1128/JVI.74.12.5395 -5402.2000.
77. Ott DE, Coren LV, Chertova EN, Gagliardi TD, Nagashima K, Sowder RC, Poon DTK, Gorelick RJ. 2003. Elimination of protease activity restores efficient virion production to a human immunodeficiency virus type 1 nucleocapsid deletion mutant. J. Virol. 77:5547-5556. http://dx.doi.org/10.1128/JVI.77.10.5547-5556.2003.
78. Muriaux D, Costes S, Nagashima K, Mirro J, Cho E, Lockett S, Rein A. 2004. Role of murine leukemia virus nucleocapsid protein in virus assembly. J. Virol. 78:12378-12385. http://dx.doi.org/10.1128/JVI.78.22.12378 -12385.2004.